PMID- 22247344 OWN - NLM STAT- MEDLINE DCOM- 20120726 LR - 20220409 IS - 1499-2752 (Electronic) IS - 0315-162X (Linking) VI - 39 IP - 3 DP - 2012 Mar TI - Interferon-gamma contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies. PG - 574-82 LID - 10.3899/jrheum.101257 [doi] AB - OBJECTIVE: HLA-B27 positivity strongly influences the susceptibility to and phenotype of spondyloarthropathies (SpA). This study was designed to screen factors that activate the promoter of HLA-B27 in U937 cells, and to assess whether these promoter-activating factors induce the unfolded protein response (UPR) in HLA-B27-expressing cells. METHODS: Cytometric Bead Array, flow cytometry, and real-time polymerase chain reaction were used to detect the expression of cytokines and UPR-associated proteins in peripheral blood and synovial fluid of patients with SpA. The HLA-B27 promotor transfectant was incubated separately with cytokines and Toll-like receptor ligands. After interferon-gamma (IFN-gamma) stimulation, expressions of GRP78, CHOP, and XBP-1 were tested in HLA-B27-expressing U937 cells and peripheral blood mononuclear cell (PBMC) of patients with ankylosing spondylitis (AS). (Clinical trial registration no. ChiCTR-OCC-11001565) RESULTS: Expressions of GRP78, CHOP, and XBP-1 in monocytes/macrophages of SpA peripheral blood and synovial fluid were higher than those in healthy controls and patients with osteoarthritis (OA) (p < 0.05). Tumor necrosis factor-alpha (TNF-alpha) and IFN-alpha, IFN-ss, and IFN-gamma were found to have activated the HLA-B27 promoter in the U937 cell line (p < 0.05). Following stimulation with IFN-gamma, the expressions of GRP78, CHOP and XBP-1 in HLA-B27-transfected U937 cells and PBMC of HLA-B27-positive AS patients were more intense than those in A2-U937 cells, HLA-B27-negative AS patients, or healthy controls (p < 0.05). CONCLUSION: Expressions of GRP78, CHOP, and XBP-1 were higher in monocytes/macrophages of patients with SpA than those in both OA patients and healthy controls, suggesting that UPR may participate in the pathogenesis of SpA. TNF-alpha and IFN-alpha, IFN-ss, and IFN-gamma significantly activated HLA-B27 promoter in the U937 cell line, and IFN-gamma, the strongest activating factor, may induce the UPR in HLA-B27-expressing cells. FAU - Feng, Yuan AU - Feng Y AD - Department of Clinical Immunology, State Key Discipline of Cell Biology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, China. FAU - Ding, Jin AU - Ding J FAU - Fan, Chun Mei AU - Fan CM FAU - Zhu, Ping AU - Zhu P LA - eng PT - Comparative Study PT - Journal Article DEP - 20120115 PL - Canada TA - J Rheumatol JT - The Journal of rheumatology JID - 7501984 RN - 0 (Cytokines) RN - 0 (DDIT3 protein, human) RN - 0 (DNA-Binding Proteins) RN - 0 (Endoplasmic Reticulum Chaperone BiP) RN - 0 (HLA-B27 Antigen) RN - 0 (HSPA5 protein, human) RN - 0 (Heat-Shock Proteins) RN - 0 (Regulatory Factor X Transcription Factors) RN - 0 (Transcription Factors) RN - 0 (X-Box Binding Protein 1) RN - 0 (XBP1 protein, human) RN - 147336-12-7 (Transcription Factor CHOP) RN - 82115-62-6 (Interferon-gamma) SB - IM EIN - J Rheumatol. 2013 Sep;40(9):1634 MH - Adult MH - Aged MH - Arthritis, Psoriatic/metabolism/pathology MH - Arthritis, Reactive/metabolism/pathology MH - Cytokines/pharmacology MH - DNA-Binding Proteins/metabolism MH - Endoplasmic Reticulum Chaperone BiP MH - Female MH - HLA-B27 Antigen/*metabolism MH - Heat-Shock Proteins/metabolism MH - Humans MH - Interferon-gamma/*pharmacology MH - Macrophages/drug effects/*metabolism/pathology MH - Male MH - Middle Aged MH - Monocytes/drug effects/*metabolism/pathology MH - Osteoarthritis/metabolism/pathology MH - Regulatory Factor X Transcription Factors MH - Spondylarthropathies/*metabolism/pathology MH - Spondylitis, Ankylosing/metabolism/pathology MH - Transcription Factor CHOP/metabolism MH - Transcription Factors/metabolism MH - U937 Cells MH - Unfolded Protein Response/*drug effects MH - X-Box Binding Protein 1 EDAT- 2012/01/17 06:00 MHDA- 2012/07/27 06:00 CRDT- 2012/01/17 06:00 PHST- 2012/01/17 06:00 [entrez] PHST- 2012/01/17 06:00 [pubmed] PHST- 2012/07/27 06:00 [medline] AID - jrheum.101257 [pii] AID - 10.3899/jrheum.101257 [doi] PST - ppublish SO - J Rheumatol. 2012 Mar;39(3):574-82. doi: 10.3899/jrheum.101257. Epub 2012 Jan 15.